Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue

S. Skadborg, S. Maarup, A. Draghi, A. Borch, I. Svane, B. Hasselbalch, H. Skovgaard Poulsen, U. Lassen, S. Hadrup

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalScandinavian Journal of Immunology
Issue number6
Publication statusPublished - 2021

Cite this